BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11527910)

  • 1. Value of magnetic resonance imaging in predicting efficacy of GnRH analogue treatment for uterine leiomyoma.
    Takahashi K; Okada M; Imaoka I; Sugimura K; Miyazaki K
    Hum Reprod; 2001 Sep; 16(9):1989-94. PubMed ID: 11527910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR detection of degenerating uterine leiomyomas.
    Okizuka H; Sugimura K; Takemori M; Obayashi C; Kitao M; Ishida T
    J Comput Assist Tomogr; 1993; 17(5):760-6. PubMed ID: 8370831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications.
    Yamashita Y; Torashima M; Takahashi M; Tanaka N; Katabuchi H; Miyazaki K; Ito M; Okamura H
    Radiology; 1993 Dec; 189(3):721-5. PubMed ID: 8234695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semiquantitative assessment of MR imaging in prediction of efficacy of gonadotropin-releasing hormone agonist for volume reduction of uterine leiomyoma: initial experience.
    Okuda S; Oshio K; Shinmoto H; Tanimoto A; Asada H; Fujii T; Yoshimura Y; Kuribayashi S
    Radiology; 2008 Sep; 248(3):917-24. PubMed ID: 18710984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR imaging in the evaluation of benign uterine masses: value of gadopentetate dimeglumine-enhanced T1-weighted images.
    Hricak H; Finck S; Honda G; Göranson H
    AJR Am J Roentgenol; 1992 May; 158(5):1043-50. PubMed ID: 1566664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the effect of gonadotropin-releasing hormone (GnRH) analogue treatment on uterine leiomyomas based on MR imaging.
    Matsuno Y; Yamashita Y; Takahashi M; Katabuchi H; Okamura H; Kitano Y; Shimamura T
    Acta Radiol; 1999 Nov; 40(6):656-62. PubMed ID: 10598858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of histopathologic features and proliferative activity of uterine leiomyoma by magnetic resonance imaging prior to GnRH analogue therapy: correlation between T2-weighted images and effect of GnRH analogue.
    Oguchi O; Mori A; Kobayashi Y; Horiuchi A; Nikaido T; Fujii S
    J Obstet Gynaecol (Tokyo 1995); 1995 Apr; 21(2):107-17. PubMed ID: 8556572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of the effects of gonadotropin-releasing hormone agonist therapy in uterine leiomyoma by T1 contrast-enhanced magnetic resonance imaging sequences.
    Kadowaki M; Murakami T; Morita J; Terada Y; Yaegashi N; Okamura K
    Fertil Steril; 2002 May; 77(5):1081-2. PubMed ID: 12009376
    [No Abstract]   [Full Text] [Related]  

  • 9. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
    Carr BR; Marshburn PB; Weatherall PT; Bradshaw KD; Breslau NA; Byrd W; Roark M; Steinkampf MP
    J Clin Endocrinol Metab; 1993 May; 76(5):1217-23. PubMed ID: 8496313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring therapy with a gonadotropin-releasing hormone analog: utility of MR imaging.
    Zawin M; McCarthy S; Scoutt L; Lange R; Lavy G; Vulte J; Comite F
    Radiology; 1990 May; 175(2):503-6. PubMed ID: 2109336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound guided high-intensity focused ultrasound combined with gonadotropin releasing hormone analogue (GnRHa) ablating uterine leiomyoma with homogeneous hyperintensity on T
    Yang S; Kong F; Hou R; Rong F; Ma N; Li S; Yang J
    Br J Radiol; 2017 May; 90(1073):20160760. PubMed ID: 28256923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient shrinkage of a uterine leiomyosarcoma treated with GnRH agonist for a presumed uterine leiomyoma: comparison of magnetic resonance imaging finding before and during GnRH agonist treatment.
    Kawamura N; Iwanaga N; Hada S; Maeda K; Sumi T; Ishiko O; Ogita S
    Oncol Rep; 2001; 8(6):1255-7. PubMed ID: 11605044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR imaging findings of uterine pyomyoma: radiologic-pathologic correlation.
    Ono H; Kanematsu M; Kato H; Toyoki H; Hayasaki Y; Furui T; Morishige K; Hatano Y
    Abdom Imaging; 2014 Aug; 39(4):797-801. PubMed ID: 24615512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A; Vollenhoven B; Sowter M
    Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid reduction of leiomyoma volume during treatment with the GnRH antagonist ganirelix.
    Flierman PA; Oberyé JJ; van der Hulst VP; de Blok S
    BJOG; 2005 May; 112(5):638-42. PubMed ID: 15842290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in the vascular bed volume of uterine fibroids after hormonal treatment: evaluation with dynamic double-echo R₂* imaging.
    Okuda S; Oshio K; Asada H; Tanimoto A; Jinzaki M; Furuya M; Yoshimura Y; Kuribayashi S
    Magn Reson Med Sci; 2012; 11(4):283-9. PubMed ID: 23269015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative MRI of uterine leiomyomas during triptorelin treatment: reproducibility of volume assessment and predictability of treatment response.
    Broekmans FJ; Heitbrink MA; Hompes PG; Schoute E; Falke T; Schoemaker J
    Magn Reson Imaging; 1996; 14(10):1127-35. PubMed ID: 9065902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter double-blind placebo-controlled study of gadopentetate dimeglumine as an MR contrast agent: evaluation in patients with cerebral lesions.
    Russell EJ; Schaible TF; Dillon W; Drayer B; LiPuma J; Mancuso A; Maravilla K; Goldstein HA
    AJR Am J Roentgenol; 1989 Apr; 152(4):813-23. PubMed ID: 2646872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadolinium-DTPA-enhanced MR imaging of spinal neoplasms: preliminary investigation and comparison with unenhanced spin-echo and STIR sequences.
    Stimac GK; Porter BA; Olson DO; Gerlach R; Genton M
    AJR Am J Roentgenol; 1988 Dec; 151(6):1185-92. PubMed ID: 3055895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.